Скачать или смотреть USFDA pain as 12 observations for Cipla Unit | Kedar Upadhye to ET Now

USFDA scare gives Cipla a severe headache. Goa unit gets 12 observations including procedural lapses. Management clarifies there is no data integrity issue & the drug-maker is in the process of responding to the red-flags. Group CFO joins ET NOW in an exclusive conversation. Listen in!

Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels:-
Times Now: http://goo.gl/U9ibPb
The NewsHour Debate: http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App:-
Android Google Play: https://goo.gl/zJhWjC
Apple App Store: https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com